Wyeth Children’s Advil Cold Combination Suspension Extends Pediatric Line
This article was originally published in The Tan Sheet
Executive Summary
Wyeth Consumer Healthcare's Advil franchise will expand into the pediatric cold category with Children's Advil Cold ibuprofen/pseudoephedrine oral suspension, which is slated to launch later this year
You may also be interested in...
Claritin, Alavert, Advil Allergy Sinus Head Major OTC Approvals In 2002
Antihistamines accounted for the most prominent OTC approvals in 2002, with Schering-Plough Healthcare Products' Claritin franchise and Wyeth Consumer Healthcare's Alavert and Advil Allergy Sinus all receiving the FDA go-ahead during the year
Advil NDA approval
Wyeth Consumer Healthcare receives agency clearance for Advil Cold & Sinus Liquigels May 30. Approved under NDA 21-374, liquigels contain 200 mg ibuprofen, 30 mg pseudoephedrine hydrochloride for "temporary relief" of cold, sinusitis or flu symptoms. Wyeth could be looking to spark new life into its cold and allergy brands, which collectively saw food, drug, mass sales drop 14% to $86 mil. for the 52 weeks ended April 21, according to data from Information Resources, Inc. (Chicago). Advil Cold & Sinus products currently rank ninth in the category, with 52-week sales totaling $40.2 mil. (down 5.2%); the line debuted in 1989. Approval is second this year for Wyeth's Advil franchise; firm will extend its pediatric line with Children's Advil Cold by year end (1"The Tan Sheet" April 29, 2002, p. 5)...
McNeil Children's Motrin Cold Liquid $8 Mil. Ad Spend Planned
The October launch of Children's Motrin Cold liquid will be supported with an $8 mil. TV and print ad campaign, McNeil Consumer Healthcare announced Aug. 14.